All Roll Calls
Yes: 227 • No: 0
Sponsored By: Michael Hornby (Republican)
Signed by Governor
Personalized for You
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Before treatment, you must sign a written, informed consent that your doctor and a witness attest. The consent explains approved treatments and says you and your doctor believe they are unlikely to prolong life. It names the investigational product and describes best and worst outcomes, including that symptoms could worsen or death be hastened. It states insurers or providers may not have to pay and that starting curative treatment can end hospice or in‑home care eligibility; hospice can restart later if you qualify. It states you may be liable for all related costs, including from your estate, unless a manufacturer contract says otherwise.
You can seek an investigational drug, biologic, or device if your doctor attests you have a life‑threatening or severely debilitating illness. You must have considered all FDA‑approved options, have your doctor recommend the investigational product, sign written informed consent (or a guardian signs), and have your doctor document that you meet these rules. This does not apply if you are an inpatient in a state‑licensed hospital. Eligible products include ones that passed phase one trials and one‑off products made just for you from your genes, like antisense oligos or neoantigen vaccines. The law uses the FDA’s definition of “life‑threatening” and “severely debilitating.”
Free Policy Watch
Pick a topic. PRIA runs your household against live legislation and sends you a free personalized readout.
Pick a topic to get started
Michael Hornby
Republican • House
There are no cosponsors for this bill.
All Roll Calls
Yes: 227 • No: 0
House vote • 3/14/2026
House concurred in Senate amendment and passed bill (Roll No. 639)
Yes: 97 • No: 0
Senate vote • 3/12/2026
Passed Senate (Roll No. 485)
Yes: 34 • No: 0
House vote • 1/29/2026
Passed House (Roll No. 31)
Yes: 96 • No: 0
Approved by Governor 4/1/2026
To Governor 3/25/2026
House received Senate message
House concurred in Senate amendment and passed bill (Roll No. 639)
Communicated to Senate
Completed legislative action
House Message received
To Governor 3/25/2026 - Senate Journal
Approved by Governor 4/1/2026 - Senate Journal
Approved by Governor 4/1/2026 - House Journal
On 3rd reading with right to amend
Read 3rd time
HHR com. amendment adopted (Voice vote)
Passed Senate (Roll No. 485)
Senate requests House to concur
On 2nd reading
Read 2nd time
Reported do pass, as amended by Health and Human Resources
Immediate consideration
Read 1st time
Reported do pass, with amendment, but first to Judiciary
To Judiciary
Introduced in Senate
To Health and Human Resources then Judiciary
To Health and Human Resources
Committee Substitute
Engrossed
Enrolled
Introduced Version
HB 5691 — Supplemental appropriation, Department of Health
HB 5692 — Supplemental appropriation, State Road Fund
HB 5684 — Relating to authorizing the Supreme Court of Appeals to create child protection commissioners
HB 5685 — Relating to authorizing bonds for improvements to the West Virginia Science and Culture Center
HB 5686 — Relating to the timing of payments of annually required deposit into an eligible recipient’s Hope Scholarship account
SB 1064 — Redefining "long-term substitute" as it relates to public school personnel
Take It Personal
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in